Moreover, a previous study reported higher CD31 + /annexin V + /CD42b- EMPs levels in SLE patients than in healthy controls and an association between CD31 + /annexin V + /CD42b- EMPs and the median global BILAG-2004 score after treatment [42]. This evidence concerns the gene PECAM1 and systemic lupus erythematosus.